Shilpa Medicare lunches pemetrexed injection in India under the brand name VRTU
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Subscribe To Our Newsletter & Stay Updated